All Updates

All Updates

icon
Filter
Partnerships
GenEdit and Genentech collaborate to develop treatments for autoimmune disease
Human Gene Editing
Jan 23, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Human Gene Editing

Human Gene Editing

Jan 23, 2024

GenEdit and Genentech collaborate to develop treatments for autoimmune disease

Partnerships

  • Gene drug developer GenEdit has entered a multi-year partnership with Genentech, a Roche Group member, to develop therapies for autoimmune diseases.

  • The partnership will leverage GenEdit's NanoGalaxy platform to develop hydrophilic nanoparticle (HNP) medications for autoimmune diseases. Genentech will take charge of preclinical, clinical, regulatory development, and product commercialization. GenEdit will receive an upfront payment of USD 15 million in advancements and milestone payments, along with royalties from global net sales. The potential financial payout for GenEdit could reach up to USD 629 million.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.